Pfizer announcement to effect Medical Sales Jobs

USA based drug giant Pfizer has announced their plans to close or sell an additional thirteen manufacturing facilities as part of its efforts to reduce the number of production plants.  The current plan is to cut the number of production plants to no more than forty four by the end of 2009, with implications for the number of medical sales jobs worldwide.

Pfizer has reported an eighteen per cent drop in income and a five percent decline in revenue for the first quarter of the year and have been scaling down their production capacity for several years.

The latest round of cuts were announced by Pfizers first quarter of results presentation and also suggested that the firm is set to decommission four of the six R&D facilities that were earmarked for closure last year.

However to put a positive slant on the news, Pfizer have what they are describing as a wide array of outsourcing opportunities which are currently at various stages of implementation.  As part of these developments, it will see a boost of the contract manufacturing and contract research sectors.